These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10332724)

  • 1. Immunization and protection in pneumococcal otitis media studied in a rat model.
    Prellner K; Hermansson A; White P; Melhus A; Briles D
    Microb Drug Resist; 1999; 5(1):73-82. PubMed ID: 10332724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A; Metzger DW
    Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Otitis media: the chinchilla model.
    Giebink GS
    Microb Drug Resist; 1999; 5(1):57-72. PubMed ID: 10332723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling specific antibody responses to natural immunization to predict a correlate of protection against infection before commencing a clinical vaccine trial.
    Almudevar A; Pichichero ME
    Hum Vaccin Immunother; 2017 Oct; 13(10):2316-2321. PubMed ID: 28892455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunisation and resistance to experimental acute pneumococcal otitis media.
    Svinhufvud M; Hermansson A; Prellner K
    Int J Pediatr Otorhinolaryngol; 1993 Jan; 25(1-3):91-103. PubMed ID: 8436484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against acute otitis media].
    Veenhoven RH; van den Berg YL; Schilder AG; Dhooge IJ; Rijkers GT; Sanders EA
    Ned Tijdschr Geneeskd; 2000 May; 144(20):931-4. PubMed ID: 10827848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A resolved pneumococcal infection protects against nontypeable Haemophilus influenzae: an evaluation of different routes of whole cell immunization in protection against experimental acute otitis media.
    Melhus A; Hermansson A; Forsgren A; Prellner K
    Int J Pediatr Otorhinolaryngol; 1997 Mar; 39(2):119-31. PubMed ID: 9104620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.
    Revai K; McCormick DP; Patel J; Grady JJ; Saeed K; Chonmaitree T
    Pediatrics; 2006 May; 117(5):1823-9. PubMed ID: 16651345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.
    Dagan R; Givon-Lavi N; Shkolnik L; Yagupsky P; Fraser D
    J Infect Dis; 2000 Apr; 181(4):1322-9. PubMed ID: 10753730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: otitis media and acute pneumonia.
    Cripps AW; Kyd JM
    Vaccine; 2007 Mar; 25(13):2471-7. PubMed ID: 17110001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children.
    Kaur R; Casey JR; Pichichero ME
    Pediatr Infect Dis J; 2011 Aug; 30(8):645-50. PubMed ID: 21487325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media.
    Jokinen JT; Ahman H; Kilpi TM; Mäkelä PH; Käyhty MH
    J Infect Dis; 2004 Aug; 190(3):545-50. PubMed ID: 15243930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental recurrent pneumococcal otitis media. Protection and serum antibodies.
    Svinhufvud M; Prellner K; Hermansson A; Schalén C
    Acta Otolaryngol; 1991; 111(6):1083-9. PubMed ID: 1763630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media.
    Simell B; Melin M; Lahdenkari M; Briles DE; Hollingshead SK; Kilpi TM; Kayhty H
    J Infect Dis; 2007 Nov; 196(10):1528-36. PubMed ID: 18008233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.
    Palmu AA; Saukkoriipi A; Jokinen J; Leinonen M; Kilpi TM
    Vaccine; 2009 Mar; 27(10):1490-1. PubMed ID: 19168111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    Eskola J; Kilpi T; Palmu A; Jokinen J; Haapakoski J; Herva E; Takala A; Käyhty H; Karma P; Kohberger R; Siber G; Mäkelä PH;
    N Engl J Med; 2001 Feb; 344(6):403-9. PubMed ID: 11172176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of active immunization with a pneumococcal surface protein (PspA) and of locally applied antibodies in experimental otitis media.
    White P; Hermansson A; Svanborg C; Briles D; Prellner K
    ORL J Otorhinolaryngol Relat Spec; 1999; 61(4):206-11. PubMed ID: 10450055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complicated otitis media and its implications.
    Leibovitz E
    Vaccine; 2008 Dec; 26 Suppl 7():G16-9. PubMed ID: 19094932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.